OTCMKTS:PURE PURE Bioscience (PURE) Stock Price, News & Analysis $0.10 +0.00 (+2.30%) As of 05/28/2025 02:26 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About PURE Bioscience Stock (OTCMKTS:PURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PURE Bioscience alerts:Sign Up Key Stats Today's Range$0.09▼$0.1050-Day Range$0.06▼$0.1352-Week Range$0.05▼$0.21Volume2,634 shsAverage Volume65,439 shsMarket Capitalization$10.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.Read More… PURE Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScorePURE MarketRank™: PURE Bioscience scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for PURE Bioscience. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PURE Bioscience is -2.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PURE Bioscience is -2.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.30% of the float of PURE Bioscience has been sold short.Short Interest Ratio / Days to CoverPURE Bioscience has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PURE Bioscience has recently increased by 1,250.36%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPURE Bioscience does not currently pay a dividend.Dividend GrowthPURE Bioscience does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.30% of the float of PURE Bioscience has been sold short.Short Interest Ratio / Days to CoverPURE Bioscience has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PURE Bioscience has recently increased by 1,250.36%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentPURE Bioscience has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for PURE Bioscience this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PURE Bioscience insiders have not sold or bought any company stock.Percentage Held by Insiders43.54% of the stock of PURE Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about PURE Bioscience's insider trading history. Receive PURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address PURE Stock News HeadlinesMeridian Bioscience Congratulates Catherine Lufkin For Receiving Pure Earth's 2025 "Force Of Nature" AwardMarch 6, 2025 | finance.yahoo.comPURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical CompanyJanuary 21, 2025 | finance.yahoo.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. May 29, 2025 | Altimetry (Ad)PURE Bioscience Unveils New Brand IdentityJanuary 9, 2025 | businesswire.comPURE Bioscience Reports Fiscal First Quarter 2025 Financial ResultsDecember 16, 2024 | businesswire.comWorld’s First NMN Manufacturer, MIRAILAB BIOSCIENCE, Launches NMN Supplements and Cosmetics in UAEDecember 5, 2024 | businesswire.comPURE Bioscience Announces Distribution Agreement with AFCO, a Zep CompanyNovember 20, 2024 | finance.yahoo.comPURE Bioscience Announces Distribution Agreement with Quip LaboratoriesNovember 1, 2024 | businesswire.comSee More Headlines PURE Stock Analysis - Frequently Asked Questions How have PURE shares performed this year? PURE Bioscience's stock was trading at $0.0638 at the beginning of 2025. Since then, PURE stock has increased by 53.6% and is now trading at $0.0980. View the best growth stocks for 2025 here. How were PURE Bioscience's earnings last quarter? PURE Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings results on Monday, March, 17th. The company reported ($0.01) EPS for the quarter. The business earned $0.39 million during the quarter. How do I buy shares of PURE Bioscience? Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PURE Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that PURE Bioscience investors own include Meta Platforms (META), Hydrofarm Holdings Group (HYFM), Twilio (TWLO), NVIDIA (NVDA), Overstock.com (OSTK), Enphase Energy (ENPH) and Novavax (NVAX). Company Calendar Last Earnings3/17/2025Today5/28/2025Fiscal Year End7/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous chemical products Sub-IndustryChemicals Current SymbolOTCMKTS:PURE CIK1006028 Webwww.purebio.com Phone(619) 596-8600Fax619-596-8790Employees10Year Founded1992Profitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.35 million Net Margins-183.96% Pretax Margin-183.96% Return on EquityN/A Return on Assets-352.61% Debt Debt-to-Equity RatioN/A Current Ratio1.00 Quick Ratio0.92 Sales & Book Value Annual Sales$1.96 million Price / Sales5.59 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-3.27Miscellaneous Outstanding Shares111,886,000Free Float63,154,000Market Cap$10.96 million OptionableNot Optionable Beta0.39 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:PURE) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PURE Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.